US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 19.560
  • +0.540+2.84%
Close Jan 17 16:00 ET
  • 19.980
  • +0.420+2.15%
Post 20:01 ET
2.43BMarket Cap-3.91P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Arrowhead Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 74.550M--
--2025/Q1-- / 19.050M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--
May 9, 20242024/Q20.000 / 56.830M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 74.550M--
--2025/Q1-- / 19.050M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--
May 9, 20242024/Q20.000 / 56.830M--

Unlock Free Earnings Estimates

Arrowhead Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 8, 2025

Buy

  • Buy

    60.00%
  • Hold

    40.00%
  • Sell

    0.00%

Price Target

No Data